A novel DMTN :: HMGA2 rearrangement drives aberrant reactivation of HMGA2 with profibrotic and type I interferon–suppressive signaling

Background HMGA2 dysregulation has been implicated in myeloid neoplasms, but its contribution to MPN pathogenesis remains to be fully understood.Methods We identified and characterized a rare DMTN:HMGA2 rearrangement using mate-pair whole-genome rearrangement sequencing in a patient with post-Essential Thrombocythemia myelofibrosis. We then investigated the functional consequences of aberrant reactivation of HMGA2 using HMGA2-overexpressing Ba/F3 and 32D hematopoietic cell models, followed by transcriptomic and functional analyzes. Finally, HMGA2-associated transcriptional programs were evaluated in clinical MPN cohorts.Results The DMTN:HMGA2 rearrangement involved the 5′UTR of DMTN and the 3′UTR of HMGA2 without generating a chimeric coding transcript, but was associated with aberrant HMGA2 activation. HMGA2 overexpression in hematopoietic cells in vitro induced a proinflammatory, profibrotic, prothrombotic, and proangiogenic transcriptional program, with upregulation of Il6, P2rx7, Ccr1, Thbs3, Sned1, Serpine1, Pgf, and Angptl2. Conversely, 121 commonly downregulated genes were enriched for type I interferon-related programs, including Ifi44, Ifit1, Oas family genes, Isg15, Irf7, Zbp1, and Mx1/2. Functionally, HMGA2 overexpression reduced IFN-α-induced STAT1/STAT2 phosphorylation, decreased IFN-α-induced apoptosis, and preserved cell proliferation following IFN-α treatment. In two independent clinical MPN cohorts, higher HMGA2 expression was consistently associated with lower activity of type I interferon and other immune-related pathways, as well as higher activity of selected mesenchymal- and stromal-related pathways.Conclusion Our findings suggest that aberrant HMGA2 reactivation can promote an inflammatory, profibrotic, and IFN-suppressive state in hematopoietic cells, providing a potential mechanistic link between HMGA2 dysregulation and MPN biology.

Authors

Institutions

Publication Details

Journal
Cancer Biology & Therapy
Published
2026-11-18
DOI
https://doi.org/10.1080/15384047.2026.2758577
Primary Topic
Myeloproliferative Neoplasms: Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

A novel DMTN :: HMGA2 rearrangement drives aberrant reactivation of HMGA2 with profibrotic and type I interferon–suppressive signaling

Jintao Xu, Xingping Lang, Sujuan Zhou, Yan Lin et al.
Cancer Biology & Therapy
Myeloproliferative Neoplasms: Diagnosis and Treatment
article

A novel DMTN :: HMGA2 rearrangement drives aberrant reactivation of HMGA2 with profibrotic and type I interferon–suppressive signaling

Jintao Xu, Xingping Lang, Sujuan Zhou, Yan Lin, Nan Chen, Fan Yang, Sheng Xiao, Mei Yang, Lijun Meng, Shouli Wang, Liying Zhang
article en

Abstract

Background HMGA2 dysregulation has been implicated in myeloid neoplasms, but its contribution to MPN pathogenesis remains to be fully understood.Methods We identified and characterized a rare DMTN:HMGA2 rearrangement using mate-pair whole-genome rearrangement sequencing in a patient with post-Essential Thrombocythemia myelofibrosis. We then investigated the functional consequences of aberrant reactivation of HMGA2 using HMGA2-overexpressing Ba/F3 and 32D hematopoietic cell models, followed by transcriptomic and functional analyzes. Finally, HMGA2-associated transcriptional programs were evaluated in clinical MPN cohorts.Results The DMTN:HMGA2 rearrangement involved the 5′UTR of DMTN and the 3′UTR of HMGA2 without generating a chimeric coding transcript, but was associated with aberrant HMGA2 activation. HMGA2 overexpression in hematopoietic cells in vitro induced a proinflammatory, profibrotic, prothrombotic, and proangiogenic transcriptional program, with upregulation of Il6, P2rx7, Ccr1, Thbs3, Sned1, Serpine1, Pgf, and Angptl2. Conversely, 121 commonly downregulated genes were enriched for type I interferon-related programs, including Ifi44, Ifit1, Oas family genes, Isg15, Irf7, Zbp1, and Mx1/2. Functionally, HMGA2 overexpression reduced IFN-α-induced STAT1/STAT2 phosphorylation, decreased IFN-α-induced apoptosis, and preserved cell proliferation following IFN-α treatment. In two independent clinical MPN cohorts, higher HMGA2 expression was consistently associated with lower activity of type I interferon and other immune-related pathways, as well as higher activity of selected mesenchymal- and stromal-related pathways.Conclusion Our findings suggest that aberrant HMGA2 reactivation can promote an inflammatory, profibrotic, and IFN-suppressive state in hematopoietic cells, providing a potential mechanistic link between HMGA2 dysregulation and MPN biology.

Cancer Biology & TherapyVol. 27(1)
Soochow University (CN), Affiliated Hospital of Nantong University (CN), The First People's Hospital of Changzhou (CN), Second Affiliated Hospital of Soochow University (CN)
Government of Jiangsu Province
Good health and well-being
Myeloproliferative Neoplasms: Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon